TerrAscend (TSNDF) Treasury Shares (2020 - 2026)
TerrAscend (TSNDF) posted quarterly Treasury Shares of $9.8 million for Q1 2026, up 537.96% year-over-year from $1.5 million in Q1 2025, and up 16.08% quarter-over-quarter from $8.5 million in Q3 2025.
TerrAscend (TSNDF) Treasury Shares (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Treasury Shares for 7 consecutive years, with $9.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 537.96% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (up 537.96% YoY), while the FY2025 annual figure was $5.0 million, up 214.27% from the prior year.
- Treasury Shares climbed to $9.8 million in Q1 2026 per TSNDF's latest filing, from $8.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $9.8 million in Q1 2026 and bottomed at $149645.0 in Q1 2022.
- Historically, Treasury Shares has averaged $2.7 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2024 — Treasury Shares surged 31.11% — and 2026, when it jumped 537.96%.
- TerrAscend's Treasury Shares stood at $415640.0 in 2022, then jumped by 159.5% to $1.1 million in 2023, then soared by 48.37% to $1.6 million in 2024, then jumped by 428.08% to $8.5 million in 2025, then advanced by 16.08% to $9.8 million in 2026.
- Business Quant data shows TSNDF's Treasury Shares at $9.8 million in Q1 2026, $8.5 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 9.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.35 Mn |
| Jun 30, 2026 | 9.35 Mn |
| Mar 31, 2026 | 9.81 Mn |
| Mar 31, 2026 | 9.81 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 999,969.00 |
| Mar 31, 2024 | 999,969.00 |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |